REGENERON PHARMACEUTICALS, INC.

Position in PBLS — Parabilis Medicines, Inc.

CIK 872589 TARRYTOWN, NY

Position in PBLS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$114,041,648

New position

Shares Held

4,166,666

first reported quarter

Ownership

3.37%

of shares outstanding

% of Portfolio

64.35%

of 13F equity value

Holder Rank

#8

of 79 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

REGENERON PHARMACEUTICALS, INC. holds $177,219,138 across 3 Biotechnology names. PBLS ranks #1 (64.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PBLS	Parabilis Medicines, Inc. This page	4,166,666	$114,041,648
2	NTLA	Intellia Therapeutics, Inc.	3,702,995	$62,654,675
3	ACET	Adicet Bio, Inc.	60,511	$522,815

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$114,041,648	4,166,666	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.